KKR assessing options after Assura rejects four takeover bids.


Private equity giant Kohlberg Kravis Roberts (KKR) confirmed on Monday that it has submitted four non-binding proposals to acquire FTSE 250 healthcare property investor Assura, with its latest offer valuing the company at £1.56bn.

  • Assura
  • 17 February 2025 08:15:24
Assura

Source: Sharecast

It said the most recent proposal, sent on 13 February, offered 48p per share in cash, representing a 28.2% premium to Assura’s closing price on that date but a slight discount to its net tangible asset value.

Assura’s board had unanimously rejected all four approaches, including the latest offer on 15 February.

The company acknowledged a preliminary approach from both KKR and USS Investment Management on 14 February, but maintained confidence in its long-term prospects, advising shareholders to take no action.

KKR said on Monday that it was considering whether to continue pursuing a potential transaction, but emphasised that there is no certainty that a formal bid will be made.

Under UK takeover rules, it has until 14 March to announce a firm intention to make an offer or withdraw, unless an extension was granted by the Takeover Panel.

Separately, USS Investment Management, which had initially been linked to the potential offer, had now ruled itself out of any bid following Assura’s rejection of KKR’s latest proposal.

Reporting by Josh White for Sharecast.com.


Exchange: London Stock Exchange
Sell:
0.00
Buy:
0.00
Change: 41.02 ( 0.20 %)
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.